Berlin, Germany — Qualifying patients will likely be able to obtain medical cannabis as early as next month, as a result of legislation recently approved by the German government.
Under the new program, regulators will license cannabis cultivation for the purpose of providing it to select patients. Individual patients will not be permitted under the law to grow their own supplies of medicinal marijuana. Health insurance providers will cover patients’ marijuana-related expenses.
During the program’s initial stages, regulators will import the product from the Netherlands and Canada. Both countries currently regulate medical marijuana production and use.
For more information, please contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org.